Eli Lilly to Acquire Scorpion Therapeutics’ STX-478 for $2.5B
US-based pharmaceutical giant Eli Lilly and Company (NYSE: LLY) is set to acquire STX-478 from...
Deals
Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6B
US-based Johnson & Johnson (J&J, NYSE: JNJ) is set to acquire all outstanding shares of...
GSK Acquires IDRx for $1B to Boost GIST Treatment Pipeline
UK-headquartered GlaxoSmithKline (GSK; NYSE: GSK) has entered into an agreement with US-based biopharma IDRx, Inc....
Autobio Diagnostics Partners with Boditech Med for Korean IVD Market
China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with South Korea-headquartered...
Henlius and Abbott Sign License Agreement for Biosimilars and Biologic Drug
China-based Shanghai Henlius Biotech Inc. (HKG: 2696) has announced a strategic license agreement with Abbott...
Bristol-Myers Squibb Exercises License for ArsenalBio’s AB-4000 Series
US-based cell therapy company Arsenal Biosciences, Inc. has announced that Bristol-Myers Squibb (BMS, NYSE: BMY)...
Gentize Biopharma Raises $13.64M in Pre-Series A for Vaccine Development
Gentize Biopharma, a clinical-stage vaccine developer based in Nanjing, has reportedly raised close to RMB...
Illumina Partners with NVIDIA to Advance Multiomic Data Analysis
US-based genomics giant Illumina (NASDAQ: ILMN) has announced a strategic partnership with chip manufacturer NVIDIA...
Mediar Therapeutics and Eli Lilly Ink Deal for IPF Drug MTX-463
US-based clinical-stage biotech Mediar Therapeutics, Inc. has announced a global license agreement with Eli Lilly...
Cornerstone Robotics Raises $68.2M in Series C to Advance Surgical Robots
Cornerstone Robotics, an innovative surgical robot developer based in Shenzhen, has reportedly raised over RMB...
Sansure Biotech to Acquire Sinobioway Hygene for $110M to Boost Product Pipeline
China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced plans to acquire 100%...
Zhaoke Ophthalmology Partners with AFT for Brimochol PF Distribution in ANZ
China-based Zhaoke Ophthalmology Ltd (HKG: 6622) has announced a strategic distribution and supply agreement with...
Neo Modulus Secures $40.9M Series C Funding for Regenerative Medical Devices
Neo Modulus (Suzhou) Medical Sci-Tech Co., Ltd., a prominent developer of regenerative implantable medical devices...
MediLink Therapeutics and AstraZeneca Collaborate on YL201 and Imfinzi Combo for Solid Tumors
Suzhou-based biotech company MediLink Therapeutics (Suzhou) Co., Ltd has announced a clinical cooperation agreement with...
Simcere Zaiming and AbbVie Ink $1.055B License Deal for MM Drug SIM0500
China-based Simcere Pharmaceutical Group Ltd (HKG: 2096) has announced a significant strategic move through its...
3SBio Acquires Licensing Rights to Duality Biologics’ HER2-Targeting ADC DB-1303
China-based 3SBio Inc. (HKG: 1530) has entered into a strategic partnership with Duality Biologics, a...
CBC Group’s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion
CBC Group’s R-Bridge Healthcare Fund has made a significant investment of USD 40 million in...
Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership
China-based Suzhou Ribo Life Science Co., Ltd has announced the achievement of a first pre-clinical...
Mabworks Biotech Licenses Anti-APRIL mAb to Climb Bio for Global Development
China-based Beijing Mabworks Biotech Co., Ltd. (NEEQ Code: 874070) has entered into a licensing deal...
Gilead Sciences and LEO Pharma Alliance Targets Inflammatory Diseases
US-based major Gilead Sciences Inc. (NASDAQ: GILD) has formed a strategic alliance with Denmark-based dermatology...